Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2015 | 2 |
2021 | 2 |
2023 | 2 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Impact of interferon beta exposure on birth outcome and child development - Results from the post-authorisation safety study PRIMA.
Mult Scler Relat Disord. 2023 Sep;77:104844. doi: 10.1016/j.msard.2023.104844. Epub 2023 Jun 24.
Mult Scler Relat Disord. 2023.
PMID: 37393802
Free article.
Pregnancy outcomes in female multiple sclerosis patients exposed to intramuscular interferon beta-1a or peginterferon beta-1a reported in a German Patient Support Programme - results from the non-interventional post-authorization safety study PRIMA.
Klehmet J, Begus-Nahrmann Y, Taipale K, Niemczyk G, Rehberg-Weber K.
Klehmet J, et al. Among authors: rehberg weber k.
Ther Adv Neurol Disord. 2023 Dec 15;16:17562864231214041. doi: 10.1177/17562864231214041. eCollection 2023.
Ther Adv Neurol Disord. 2023.
PMID: 38107443
Free PMC article.
Item in Clipboard
Peginterferon beta-1a was associated with high adherence and satisfaction in patients with multiple sclerosis in a German real-world study.
Menge T, Rehberg-Weber K, Taipale K, Nastos I, Jauß M.
Menge T, et al. Among authors: rehberg weber k.
Ther Adv Neurol Disord. 2021 Mar 19;14:17562864211000461. doi: 10.1177/17562864211000461. eCollection 2021.
Ther Adv Neurol Disord. 2021.
PMID: 33796146
Free PMC article.
Item in Clipboard
Subcutaneous Interferon Beta Therapy in Multiple Sclerosis Patients - Characterization of Injection Site Reactions and Flu-Like Symptoms in a Daily Practice Setting - Results from the Non-Interventional Study PERFECT.
Kukowski B, Rehberg-Weber K, Taipale K, Kowalik A, Oschmann P.
Kukowski B, et al. Among authors: rehberg weber k.
Patient Prefer Adherence. 2021 May 24;15:1091-1100. doi: 10.2147/PPA.S307987. eCollection 2021.
Patient Prefer Adherence. 2021.
PMID: 34079229
Free PMC article.
Item in Clipboard
Adherence and cost in multiple sclerosis patients treated with IM IFN beta-1a: impact of the CARE patient management program.
Katsarava Z, Ehlken B, Limmroth V, Taipale K, Patel SN, Niemczyk G, Rehberg-Weber K, Wernsdörfer C; C.A.R.E. Study Group.
Katsarava Z, et al. Among authors: rehberg weber k.
BMC Neurol. 2015 Sep 22;15:170. doi: 10.1186/s12883-015-0426-x.
BMC Neurol. 2015.
PMID: 26395989
Free PMC article.
Item in Clipboard
Interferon Beta-1a (AVONEX®) as a Treatment Option for Untreated Patients with Multiple Sclerosis (AXIOM): A Prospective, Observational Study.
Kleinschnitz C, Niemczyk G, Rehberg-Weber K, Wernsdörfer C.
Kleinschnitz C, et al. Among authors: rehberg weber k.
Int J Mol Sci. 2015 Jul 6;16(7):15271-86. doi: 10.3390/ijms160715271.
Int J Mol Sci. 2015.
PMID: 26154767
Free PMC article.
Item in Clipboard
Cite
Cite